RENAL CELL CARCINOMA STAGE UNSPECIFIED

This adverse event was reported 568 times

These drugs are most commonly taken by patients reporting RENAL CELL CARCINOMA STAGE UNSPECIFIED:

# Drug Count
0 METHOTREXATE SODIUM 45
1 INFLIXIMAB 40
2 METHOTREXATE 40
3 AMLODIPINE BESYLATE 36
4 ATORVASTATIN CALCIUM 35
5 SORAFENIB 35
6 INTERFERON BETA-1A 32
7 ASPIRIN 30
8 SUNITINIB MALATE 29
9 ASPIRIN 325 MG 28
See all common drugs associated with RENAL CELL CARCINOMA STAGE UNSPECIFIED

RENAL CELL CARCINOMA STAGE UNSPECIFIED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DACTINOMYCIN 7 0.0032
1 THIOGUANINE 6 0.0028
2 SORAFENIB 35 0.0017
3 ALDESLEUKIN 2 0.0016
4 FLUCYTOSINE 2 0.0014
5 FOSINOPIRL SODIUM 2 0.0009
6 THALIDOMIDE 28 0.0008
7 SUNITINIB MALATE 29 0.0007
8 FOSINOPRIL 2 0.0005
9 NABUMETONE 3 0.0005
See all drugs enriched for association with RENAL CELL CARCINOMA STAGE UNSPECIFIED

RENAL CELL CARCINOMA STAGE UNSPECIFIED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 7 0.0032
1 Lymphocyte Growth Factor [EPC] 2 0.0016
2 Nucleoside Analog Antifungal [EPC] 2 0.0014
3 Calcitonin [EPC] 1 0.0003
4 Topoisomerase Inhibitor [EPC] 22 0.0003
5 CD33-directed Immunoconjugate [EPC] 1 0.0003
6 Photoenhancer [EPC] 1 0.0003
7 Lipid-based Polyene Antifungal [EPC] 3 0.0002
8 Insulin [EPC] 10 0.0002
9 Catechol-O-Methyltransferase Inhibitor [EPC] 1 0.0002
See all drug classes enriched for association with RENAL CELL CARCINOMA STAGE UNSPECIFIED